Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solventum (SOLV) Short term Debt (2024 - 2026)

Solventum posted quarterly Short term Debt of $505.0 million for Q1 2026, up 405.0% year-on-year from $100.0 million in Q1 2025, and up 405.0% on a QoQ basis from $100.0 million in Q1 2025.

Solventum (SOLV) has 3 years of Short term Debt data on file, last reported at $505.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Short term Debt rose 405.0% year-over-year to $505.0 million; the trailing twelve-month figure through Mar 2026 stood at $505.0 million (up 405.0% YoY), and the FY2024 full-year result was $200.0 million, changed N/A from the prior year.
  • Short term Debt for Q1 2026 stood at $505.0 million, up from $100.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $505.0 million in Q1 2026 and bottomed at $100.0 million in Q1 2025.
  • The 3-year median for Short term Debt is $250.0 million (2024), against an average of $276.2 million.
  • Peak annual rise in Short term Debt reached 405.0% in 2026, while the deepest fall reached 405.0% in 2026.
  • A 3-year view of Short term Debt shows it stood at $200.0 million in 2024, then sank by 50.0% to $100.0 million in 2025, then soared by 405.0% to $505.0 million in 2026.
  • The last three Short term Debt figures came in at $505.0 million (Q1 2026), $100.0 million (Q1 2025), and $200.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 505.00 Mn
Mar 31, 2025 100.00 Mn
Dec 31, 2024 200.00 Mn
Sep 30, 2024 300.00 Mn